Prestige Consumer Healthcare (PBH) 10-Q2 Aug 182019 Q1 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Jul. 27, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Prestige Brands Holdings, Inc.
Entity Central Index Key	1,295,947
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2,019
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		51,733,565

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Revenues
Total revenues	$ 253,980	$ 256,573
Cost of Sales
Cost of sales excluding depreciation	112,069	111,757
Cost of sales depreciation	1,288	1,340
Cost of sales	113,357	113,097
Gross profit	140,623	143,476
Operating Expenses
Advertising and promotion	37,111	36,944
General and administrative	23,941	20,410
Depreciation and amortization	7,084	7,167
Total operating expenses	68,136	64,521
Operating income	72,487	78,955
Other (income) expense
Interest income	(100)	(69)
Interest expense	26,040	26,410
Other expense (income), net	87	(74)
Total other expense	26,027	26,267
Income before income taxes	46,460	52,688
Provision for income taxes	11,994	18,929
Net income	$ 34,466	$ 33,759
Earnings per share:
Basic (in USD per share)	$ 0.65	$ 0.64
Diluted (in USD per share)	$ 0.65	$ 0.63
Weighted average shares outstanding:
Basic (in shares)	52,640	53,038
Diluted (in shares)	52,942	53,509
Comprehensive income, net of tax:
Currency translation adjustments	$ (2,974)	$ 1,119
Unrecognized net gain on pension plans	0	1
Total other comprehensive (loss) income	(2,974)	1,120
Comprehensive income	31,492	34,879
Net sales
Revenues
Total revenues	253,954	256,487
Other revenues
Revenues
Total revenues	$ 26	$ 86

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Current assets
Cash and cash equivalents	$ 34,269	$ 32,548
Accounts receivable, net of allowance of $13,524 and $12,734, respectively	150,390	140,881
Inventories	118,957	118,547
Deferred income tax assets	0	26
Prepaid expenses and other current assets	10,862	11,475
Total current assets	314,478	303,477
Property, plant and equipment, net	52,453	52,552
Goodwill	612,966	620,098
Intangible assets, net	2,722,542	2,780,916
Other long-term assets	3,415	3,569
Assets held for sale	62,866	0
Total Assets	3,768,720	3,760,612
Current liabilities
Accounts payable	78,405	61,390
Accrued interest payable	13,844	9,708
Other accrued liabilities	50,011	52,101
Total current liabilities	142,260	123,199
Long-term debt, net	1,993,803	1,992,952
Deferred income tax liabilities	447,855	442,518
Other long-term liabilities	23,079	23,333
Total Liabilities	2,606,997	2,582,002
Commitments and Contingencies — Note 16
Stockholders' Equity
Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None	0	0
Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 53,603 shares at June 30, 2018 and 53,396 shares at March 31, 2018	536	534
Additional paid-in capital	471,318	468,783
Treasury stock, at cost - 1,871 shares at June 30, 2018 and 353 shares at March 31, 2018	(59,928)	(7,669)
Accumulated other comprehensive loss, net of tax	(22,289)	(19,315)
Retained earnings	772,086	736,277
Total Stockholders' Equity	1,161,723	1,178,610
Total Liabilities and Stockholders' Equity	$ 3,768,720	$ 3,760,612

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable, current	$ 13,524	$ 12,734
Stockholders' Equity:
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	53,603,000	53,396,000
Treasury stock (in shares)	1,871,000	353,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating Activities
Net income	$ 34,466	$ 33,759
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,372	8,507
Loss on disposal of property and equipment	1	490
Deferred income taxes	6,755	9,225
Amortization of debt origination costs	920	1,746
Excess tax benefits from share-based awards	0	302
Stock-based compensation costs	1,657	1,713
Changes in operating assets and liabilities:
Accounts receivable	(4,357)	1,543
Inventories	(9,303)	(2,899)
Prepaid expenses and other current assets	623	9,604
Accounts payable	16,479	(8,024)
Accrued liabilities	347	(1,558)
Other	(108)	(287)
Net cash provided by operating activities	55,852	54,121
Investing Activities
Purchases of property, plant and equipment	(2,469)	(2,554)
Acquisition of Fleet escrow receipt	0	970
Net cash used in investing activities	(2,469)	(1,584)
Financing Activities
Term loan repayments	0	(50,000)
Borrowings under revolving credit agreement	20,000	0
Repayments under revolving credit agreement	(20,000)	0
Proceeds from exercise of stock options	880	433
Fair value of shares surrendered as payment of tax withholding	(2,281)	(1,027)
Repurchase of common stock	(49,978)	0
Net cash used in financing activities	(51,379)	(50,594)
Effects of exchange rate changes on cash and cash equivalents	(283)	337
Increase in cash and cash equivalents	1,721	2,280
Cash and cash equivalents - beginning of period	32,548	41,855
Cash and cash equivalents - end of period	34,269	44,135
Interest paid	20,907	24,298
Income taxes paid	$ 334	$ 2,230

Business and Basis of Presentat

Business and Basis of Presentation	3 Months Ended
Business and Basis of Presentation	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation Nature of Business Prestige Brands Holdings, Inc. (referred to herein as the “Company” or “we,” which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (“OTC”) healthcare and household cleaning products to mass merchandisers and drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets. Prestige Brands Holdings, Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 8. Basis of Presentation The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., “ 2019 ”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2018 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2019 . These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2018 . Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Reclassification In accordance with Accounting Standards Update ("ASU") 2017-07, we have reclassified net periodic benefit costs related to our pension plans from general and administrative expense to other (income) expense. The impact of this reclassification on our financial statements was less than $1.0 million . Recently Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , including new FASB Accounting Standards Codification ("ASC") 606, which supersedes the revenue recognition requirements in FASB ASC 605. Along with amendments issued in 2015 and 2016, the new guidance eliminates industry-specific revenue recognition guidance under current GAAP and replaces it with a principle-based approach for determining revenue. The core principle of the new guidance is that an entity should recognize revenue for the transfer of goods and services equal to an amount it expects to be entitled to receive for those goods and services. The new standard also requires additional disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. The new guidance permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively by recognizing the cumulative effect of initially applying the guidance to all contracts existing at the date of initial application (the modified retrospective method). The ASU, as amended, is effective for annual reporting periods beginning after December 15, 2017. We adopted this guidance effective April 1, 2018 using the modified retrospective transition method and applied it to contracts that were not completed at the adoption date. See Note 2 for our revenue recognition policy. The effects of this recently adopted accounting pronouncement to our consolidated balance sheet as of April 1, 2018 are as follows: (In thousands) Balance March 31, 2018 New Revenue Standard Adjustment Balance April 1, 2018 Accounts receivable, net $ 140,881 $ 5,438 $ 146,319 Inventories 118,547 (1,768 ) 116,779 Other accrued liabilities 52,101 1,925 54,026 Deferred income tax liabilities 442,518 401 442,919 Retained earnings 736,277 1,344 737,621 In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which changes the presentation of net periodic benefit cost related to employer sponsored defined benefit plans and other postretirement benefits. Under this ASU, service cost should be included in the same income statement line item as other compensation costs arising from services rendered during the period, while other components of net periodic benefit pension cost should be presented separately outside of operating income. Additionally, only service costs may be capitalized in assets. Entities should apply the guidance on the presentation of the components of net periodic benefit cost in the income statement retrospectively. The guidance limiting the capitalization of net periodic benefit cost in assets to the service cost component should be applied prospectively. The standard is effective for annual reporting periods beginning after December 15, 2017. The adoption of this standard in the first quarter of 2019 required us to reclassify certain pension costs out of operating income and did not have a material impact on our consolidated financial statements. In March 2018, the FASB issued ASU 2018-05, Income Taxes (Topic 740) . The amendments in this update reflect the income tax accounting implications of the Tax Cuts and Jobs Act ("Tax Act"). See Note 14 for a discussion of the Tax Act, which was signed into law on December 22, 2017, and the impact it has had, and may have, on our business and financial results. In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. See Note 14 for a discussion of the Tax Act, which was signed into law on December 22, 2017, and the impact it has had, and may have, on our business and financial results. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We have early adopted ASU 2018-02, and the adoption did not have a material impact on our consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We adopted this standard effective April 1, 2018 and the adoption did not have a material impact to our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments . The amendments in this update provide clarification and guidance on eight cash flow classification issues. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. We adopted this standard effective April 1, 2018, and the adoption did not have a material impact to our consolidated financial statements. Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) . The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our consolidated financial statements and whether to early adopt this ASU. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB ASC Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are in the process of analyzing our lease portfolio and evaluating the impact of adopting this guidance on our consolidated financial statements.

Revenue Recognition

Revenue Recognition	3 Months Ended
Revenue Recognition	Jun. 30, 2018
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Nature of Goods and Services We recognize revenue from product sales. We primarily ship finished goods to our customers and operate in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The segments are based on differences in the nature of products and geographical area. The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough & Cold, Women's Health, Gastrointestinal, Eye & Ear Care, Dermatologicals, and Oral Care. The Household Cleaning segment focuses on the sale of cleaning products. Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation. We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers and drug, food, dollar, convenience and club stores and e-commerce channels, all of which sell our products to consumers. See Note 18 for disaggregated revenue information. Satisfaction of Performance Obligations Revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to in exchange for that good. This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer’s carrier. This represents a change in the timing of revenue recognition for some sales. Refer to the table above in Note 1 for a disclosure of the adoption date impacts. Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. Variable Consideration Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales. We record an estimate of future product returns concurrent with recording sales, which is made using the most likely amount method which incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. We participate in the promotional programs of our customers to enhance the sale of our products. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place. Estimates of the costs of these promotional programs are derived using the most likely amount method which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. At the completion of the promotional program, the estimated amounts are adjusted to actual results. Practical Expedients Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to remaining performance obligations disclosure. Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time. Accordingly, we have elected the practical expedient available under ASC 606 not to disclose remaining performance obligations for our contracts. The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less. As such, we do not adjust product consideration for the effects of a significant financing component. The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. As such, we expense commission and broker fees as incurred. We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods. The impact of adopting ASC 606 on our Condensed Consolidated Statements of Income and Comprehensive Income is as follows: Three Months Ended June 30, 2018 (In thousands) As Reported Impact of Change Without Adoption of ASC 606 Total revenues $ 253,980 $ (5,945 ) $ 248,035 Cost of sales $ 113,357 $ (2,192 ) $ 111,165 Total operating expenses $ 68,136 $ (139 ) $ 67,997 Provision for income taxes $ 11,994 $ (981 ) $ 11,013 Net income $ 34,466 $ (2,633 ) $ 31,833

Assets Held for Sale

Assets Held for Sale	3 Months Ended
Assets Held for Sale	Jun. 30, 2018
Discontinued Operations and Disposal Groups [Abstract]
Assets Held for Sale	Assets Held for Sale In the first quarter of fiscal 2019, we were approached and discussed the potential to sell certain of our Household Cleaning business assets. Prior to these discussions, we did not contemplate any divestitures, and we did not commit to any course of action to divest any of the assets. On July 2, 2018, we sold the Comet®, Spic and Span®, Chore Boy®, Chlorinol® and Cinch® brands, as well as associated inventory. These brands represented our Household Cleaning segment. The gain/loss on sale will be recorded in the second quarter of fiscal 2019 and will not be material to our financial statements. See Note 19 for further information. This transaction met the criteria as held for sale as of June 30, 2018, and the related assets were measured at the lower of the carrying value or fair value less any costs to sell based upon the agreed upon price. As a result, as of June 30, 2018, we recorded the held for sale assets at their estimated fair values. The total assets held for sale related to this sale were: (In thousands) June 30, 2018 Components of assets held for sale: Inventories $ 6,644 Property, plant and equipment, net 662 Goodwill 6,245 Intangible assets, net 49,315 Assets held for sale $ 62,866

Inventories

Inventories	3 Months Ended
Inventories	Jun. 30, 2018
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following: (In thousands) June 30, 2018 March 31, 2018 Components of Inventories Packaging and raw materials $ 16,197 $ 13,112 Work in process 223 157 Finished goods 102,537 105,278 Inventories $ 118,957 $ 118,547 Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $2.8 million and $4.2 million at June 30, 2018 and March 31, 2018 , respectively, related to obsolete and slow-moving inventory.

Goodwill

Goodwill	3 Months Ended
Goodwill	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC International OTC Household Consolidated Balance - March 31, 2018 Goodwill $ 711,104 $ 32,919 $ 71,405 $ 815,428 Accumulated impairment loss (130,170 ) — (65,160 ) (195,330 ) Balance - March 31, 2018 580,934 32,919 6,245 620,098 2019 Reclassified to assets held for sale — — (6,245 ) (6,245 ) Effects of foreign currency exchange rates — (887 ) — (887 ) Balance - June 30, 2018 Goodwill 711,104 32,032 65,160 808,296 Accumulated impairment loss (130,170 ) — (65,160 ) (195,330 ) Balance - June 30, 2018 $ 580,934 $ 32,032 $ — $ 612,966 As discussed in Note 3, on July 2, 2018, we sold our Household Cleaning segment. As a result, we decreased goodwill by $6.2 million . Under accounting guidelines, goodwill is not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount. On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment. At February 28, 2018 , during our annual test for goodwill impairment, there were no indicators of impairment under the analysis. Accordingly, no impairment charge was recorded in fiscal 2018 . We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test. We also considered our market capitalization at February 28, 2018 , which was the date of our annual review, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increasing competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require an impairment charge to be recorded in the future. As of June 30, 2018 , no events have occurred that would indicate potential impairment of goodwill.

Intangible Assets, net

Intangible Assets, net	3 Months Ended
Intangible Assets, net	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, net	Intangible Assets, net A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2018 $ 2,490,303 $ 441,314 $ 2,931,617 Reclassified to assets held for sale (30,562 ) (34,889 ) (65,451 ) Effects of foreign currency exchange rates (3,089 ) (190 ) (3,279 ) Balance — June 30, 2018 2,456,652 406,235 2,862,887 Accumulated Amortization Balance — March 31, 2018 — 150,701 150,701 Additions — 5,812 5,812 Reclassified to assets held for sale — (16,136 ) (16,136 ) Effects of foreign currency exchange rates — (32 ) (32 ) Balance — June 30, 2018 — 140,345 140,345 Intangible assets, net — June 30, 2018 $ 2,456,652 $ 265,890 $ 2,722,542 As discussed in Note 3, on July 2, 2018, we sold our Household Cleaning segment. As a result, we decreased our indefinite lived intangibles by $30.5 million and our net finite-lived trademarks by $18.8 million . Amortization expense was $5.8 million for the three months ended June 30, 2018 , and $5.9 million for the three months ended June 30, 2017 . Based on our amortizable intangible assets as of June 30, 2018 , amortization expense is expected to be approximately $16.1 million for the remainder of fiscal 2019 , $21.5 million in fiscal 2020 , $21.1 million in fiscal 2021 , $20.6 million in fiscal 2022 , $20.6 million in fiscal 2023 and $20.6 million in fiscal 2024 . Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life. Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value. On an annual basis during the fourth fiscal quarter, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of both the values and, if applicable, useful lives assigned to intangible assets and tests for impairment. The date of our annual impairment review was February 28, 2018 , and we recorded impairment charges in our March 31, 2018 financial statements. We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. The discount rate utilized in the analyses, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation. Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer preferences, technological advances or reductions in advertising and promotional expenses, we may be required to record impairment charges in the future. As of June 30, 2018 , no events have occurred that would indicate further potential impairment of intangible assets.

Other Accrued Liabilities

Other Accrued Liabilities	3 Months Ended
Other Accrued Liabilities	Jun. 30, 2018
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other Accrued Liabilities Other accrued liabilities consist of the following: (In thousands) June 30, 2018 March 31, 2018 Accrued marketing costs $ 26,772 $ 21,473 Accrued compensation costs 4,658 10,591 Accrued broker commissions 1,174 1,487 Income taxes payable 18 1,901 Accrued professional fees 1,997 2,244 Accrued production costs 8,747 7,392 Other accrued liabilities 6,645 7,013 $ 50,011 $ 52,101

Long-Term Debt

Long-Term Debt	3 Months Ended
Long-Term Debt	Jun. 30, 2018
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt At June 30, 2018 , we had $75.0 million outstanding on the asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and an additional borrowing capacity of $98.9 million . Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, 2018 March 31, 2018 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 600,000 $ 600,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00% with a floor of 1.00% due on January 26, 2024. 938,000 938,000 2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 26, 2022. 75,000 75,000 Long-term debt 2,013,000 2,013,000 Less: unamortized debt costs (19,197 ) (20,048 ) Long-term debt, net $ 1,993,803 $ 1,992,952 As of June 30, 2018 , aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the 6.375% senior unsecured notes due 2024 (the "2016 Senior Notes") and the 5.375% senior unsecured notes due 2021 (the "2013 Senior Notes") are as follows: (In thousands) Year Ending March 31, Amount 2019 (remaining nine months ending March 31, 2019) $ — 2020 — 2021 — 2022 475,000 2023 437 Thereafter 1,537,563 $ 2,013,000

Fair Value Measurements

Fair Value Measurements	3 Months Ended
Fair Value Measurements	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts. FASB ASC 820, Fair Value Measurements , requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created: Level 1 - Quoted market prices for identical instruments in active markets; Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant. The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2016 Senior Notes, the 2013 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2018 and March 31, 2018 ). June 30, 2018 March 31, 2018 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 600,000 $ 597,000 $ 600,000 $ 610,500 2013 Senior Notes 400,000 401,000 400,000 402,000 2012 Term B-5 Loans 938,000 934,483 938,000 939,173 2012 ABL Revolver 75,000 75,000 75,000 75,000 At June 30, 2018 and March 31, 2018 , we did not have any assets or liabilities measured in Level 1 or 3. Nonrecurring Fair Value Measurements In addition to the recurring fair value measurements disclosed above, as of June 30, 2018 we recorded the long-lived held for sale assets (discussed in Note 3) at fair value, using Level 3 inputs. The fair value of the associated assets approximated their carrying value and, as such, no loss was recorded.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
Stockholders' Equity	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends. No dividends have been declared or paid on our common stock through June 30, 2018 . During the three months ended June 30, 2018 and 2017 , we repurchased 68,939 shares and 19,616 shares, respectively, of restricted common stock from our employees pursuant to the provisions of various employee restricted stock awards. The repurchases for the three months ended June 30, 2018 and 2017 were at an average price of $33.09 and $52.36 . All of the repurchased shares have been recorded as treasury stock. During the three months ended June 30, 2018 , we repurchased 1,449,750 shares of our common stock in conjunction with our share repurchase program. The repurchases were at an average price of $34.47 per share, totaled $50.0 million , and have been recorded as treasury stock.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
Accumulated Other Comprehensive Loss	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Accumulated other comprehensive loss consisted of the following at June 30, 2018 and March 31, 2018 : (In thousands) June 30, 2018 March 31, 2018 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (23,372 ) $ (20,398 ) Unrecognized net gain on pension plans 1,083 1,083 Accumulated other comprehensive loss, net of tax $ (22,289 ) $ (19,315 ) As of June 30, 2018 and March 31, 2018 , no amounts were reclassified from accumulated other comprehensive income into earnings.

Earnings Per Share

Earnings Per Share	3 Months Ended
Earnings Per Share	Jun. 30, 2018
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed based on income available to common stockholders and the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based on income available to common stockholders and the weighted-average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs"). Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and nonvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive. In loss periods, the assumed exercise of in-the-money stock options and restricted stock units has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2018 2017 Numerator Net income $ 34,466 $ 33,759 Denominator Denominator for basic earnings per share — weighted average shares outstanding 52,640 53,038 Dilutive effect of nonvested restricted stock units and options issued to employees and directors 302 471 Denominator for diluted earnings per share 52,942 53,509 Earnings per Common Share: Basic earnings per share $ 0.65 $ 0.64 Diluted earnings per share $ 0.65 $ 0.63 For the three months ended June 30, 2018 and 2017 , there were 0.8 million and 0.4 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.

Share-Based Compensation

Share-Based Compensation	3 Months Ended
Share-Based Compensation	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	Share-Based Compensation In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the “Plan”), which provides for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, RSUs and other equity-based awards. In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the Plan, an increase of the maximum number of shares subject to stock options that may be awarded to any one participant under the Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and an extension of the term of the Plan by ten years, to February 2025. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan. During the three months ended June 30, 2018 and 2017 , pre-tax share-based compensation costs charged against income were $1.7 million and $1.7 million , respectively, and the related income tax benefit recognized was $0.2 million and $0.5 million , respectively. At June 30, 2018 , there were $11.3 million of unrecognized compensation costs related to nonvested share-based compensation arrangements under the Plan, based on management's estimate of the shares that will ultimately vest. We expect to recognize such costs over a weighted-average period of 1.1 years. The total fair value of options and RSUs vested during the three months ended June 30, 2018 and 2017 was $10.7 million and $4.9 million , respectively. For the three months ended June 30, 2018 and 2017 , we received cash from the exercise of stock options of $0.9 million and $0.4 million , respectively. For the three months ended June 30, 2018 and 2017 , we realized $1.2 million and $0.9 million , respectively, in tax benefits from the tax deductions resulting from RSU issuances and stock option exercises. At June 30, 2018 , there were 1.8 million shares available for issuance under the Plan. On May 7, 2018, the Compensation and Talent Management Committee of our Board of Directors granted 103,406 performance stock units, 100,399 RSUs and stock options to acquire 294,484 shares of our common stock to certain executive officers and employees under the Plan. The stock options were granted at an exercise price of $29.46 per share, which was equal to the closing price for our common stock on the date of the grant. Restricted Stock Units RSUs granted to employees under the Plan generally vest in three years, primarily upon the attainment of certain time vesting thresholds, and, in the case of performance share units, may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before income taxes, depreciation and amortization targets. The RSUs provide for accelerated vesting if there is a change of control, as defined in the Plan. The RSUs granted to employees generally vest either ratably over three years or in their entirety on the three -year anniversary of the date of the grant. Upon vesting, the units will be settled in shares of our common stock. Termination of employment prior to vesting will result in forfeiture of the RSUs, unless otherwise accelerated by the Compensation and Talent Management Committee or, in the case of RSUs granted in May 2017 and 2018, subject to pro-rata vesting in the event of death, disability or retirement. The RSUs granted to directors vest immediately upon grant, and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. A summary of the RSUs granted under the Plan is presented below: RSUs Shares (in thousands) Weighted- Average Grant-Date Fair Value Three Months Ended June 30, 2017 Vested and nonvested at March 31, 2017 350.1 $ 39.29 Granted 90.4 56.11 Vested and issued (50.8 ) 34.28 Forfeited (2.3 ) 50.06 Vested and nonvested at June 30, 2017 387.4 43.81 Vested at June 30, 2017 63.7 20.31 Three Months Ended June 30, 2018 Vested and nonvested at March 31, 2018 393.5 $ 44.13 Granted 203.8 29.46 Vested and issued (173.4 ) 43.00 Forfeited (31.1 ) 48.32 Vested and nonvested at June 30, 2018 392.8 36.68 Vested at June 30, 2018 90.5 29.88 Options The Plan provides that the exercise price of options granted shall be no less than the fair market value of our common stock on the date the options are granted. Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three to five years. The option awards provide for accelerated vesting in the event of a change in control, as defined in the Plan. Except in the case of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the nonvested stock options. Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the Plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below. Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies. We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the options granted are derived from our historical experience, management's estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options. The weighted-average grant-date fair values of the options granted during the three months ended June 30, 2018 and 2017 were $10.22 and $21.20 , respectively. Three Months Ended June 30, 2018 2017 Expected volatility 29.6 % 35.2 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 2.9 % 2.2 % A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three Months Ended June 30, 2017 Outstanding at March 31, 2017 772.3 $ 37.70 Granted 182.8 56.11 Exercised (13.8 ) 31.35 Forfeited or expired (5.8 ) 32.64 Outstanding at June 30, 2017 935.5 41.42 7.7 $ 12,123 Exercisable at June 30, 2017 527.3 31.95 6.5 $ 11,305 Three Months Ended June 30, 2018 Outstanding at March 31, 2018 873.2 $ 41.79 Granted 294.5 29.46 Exercised (32.8 ) 26.81 Forfeited or expired (72.7 ) 45.00 Outstanding at June 30, 2018 1,062.2 38.61 7.6 $ 6,573 Exercisable at June 30, 2018 599.8 37.99 6.2 $ 4,054 The aggregate intrinsic value of options exercised during the three months ended June 30, 2018 was $0.3 million .

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Act. The Tax Act represents significant U.S. federal tax reform legislation that includes a permanent reduction to the U.S. federal corporate income tax rate. The permanent reduction to the federal corporate income tax rate resulted in a one-time gain of $267.0 million related to the value of our deferred tax liabilities and a gain of $3.2 million related to the lower blended tax rate on our earnings, in the year ended March 31, 2018, resulting in a net gain of $270.2 million . Additionally, the Tax Act subjects certain of our cumulative foreign earnings and profits to U.S. income taxes through a deemed repatriation, which resulted in a charge of $1.9 million in the year ended March 31, 2018. The changes included in the Tax Act are broad and complex. The final transition impacts of the Tax Act may differ from the above estimate, possibly materially, due to, among other things, changes in interpretations of the Tax Act, any legislative action to address questions that arise because of the Tax Act, any changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or any updates or changes to estimates we have utilized to calculate the transition impacts, including impacts from changes to current year earnings estimates and foreign exchange rates of foreign subsidiaries. The U.S. Securities and Exchange Commission has issued rules that would allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. We currently anticipate finalizing and recording any resulting adjustment by the end of the measurement period. Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur. The effective rates used in the calculation of income taxes were 25.8% and 35.9% for the three months ended June 30, 2018 and 2017 , respectively. The decrease in the effective tax rate for the three months ended June 30, 2018 was primarily due to the Tax Act. The balance in our uncertain tax liability was $10.8 million at June 30, 2018 and at March 31, 2018 . We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. We did not incur any material interest or penalties related to income taxes in any of the periods presented.

Employee Retirement Plans

Employee Retirement Plans	3 Months Ended
Employee Retirement Plans	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Retirement Plans	Employee Retirement Plans The primary components of Net Periodic Benefits consist of the following: (In thousands) Three Months Ended June 30, 2018 Three Months Ended June 30, 2017 Interest cost $ 610 629 Expected return on assets (768 ) (726 ) Net periodic benefit income $ (158 ) $ (97 ) During the three months ended June 30, 2018 , we contributed $0.1 million to our non-qualified defined benefit plan and made no contributions to the qualified defined benefit plan. During the remainder of fiscal 2019 , we expect to contribute an additional $0.3 million to our non-qualified plan and make a contribution of $1.0 million to the qualified plan.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are involved from time to time in legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.

Concentrations of Risk

Concentrations of Risk	3 Months Ended
Concentrations of Risk	Jun. 30, 2018
Risks and Uncertainties [Abstract]
Concentrations of Risk	Concentrations of Risk Our revenues are concentrated in the areas of OTC Healthcare and Household Cleaning products. We sell our products to mass merchandisers and drug, food, dollar, convenience and club stores and e-commerce channels. During the three months ended June 30, 2018 and 2017 , approximately 42.6% and 43.2% , respectively, of our gross revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for both of the periods presented. Walmart accounted for approximately 24.6% and 25.5% , respectively, of our gross revenues for the three months ended June 30, 2018 and 2017 , respectively. At June 30, 2018 , approximately 25.2% of accounts receivable were owed by Walmart. We manage product distribution in the continental United States through a third-party distribution center in St. Louis, Missouri. A serious disruption, such as an earthquake, tornado, flood or fire, to the main distribution center could damage our inventories and could materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost. We could incur significantly higher costs and experience longer lead times associated with the distribution of our products to our customers during the time that it takes us to reopen or replace our distribution center. As a result, any such disruption could have a material adverse effect on our business, sales and profitability. At June 30, 2018 , we had relationships with 116 third-party manufacturers. Of those, we had long-term contracts with 38 manufacturers that produced items that accounted for approximately 61.9% of gross sales for the three months ended June 30, 2018 . At June 30, 2017 , we had relationships with 116 third-party manufacturers. Of those, we had long-term contracts with 48 manufacturers that produced items that accounted for approximately 77.2% of gross sales for the three months ended June 30, 2017 . The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations. Although we are in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.

Business Segments

Business Segments	3 Months Ended
Business Segments	Jun. 30, 2018
Segment Reporting [Abstract]
Business Segments	Business Segments Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare, (ii) International OTC Healthcare and (iii) Household Cleaning. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and promotional expenses. The tables below summarize information about our reportable segments Three Months Ended June 30, 2018 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 214,775 $ 19,394 $ 19,811 $ 253,980 Cost of sales 89,153 7,616 16,588 113,357 Gross profit 125,622 11,778 3,223 140,623 Advertising and promotion 33,258 3,423 430 37,111 Contribution margin $ 92,364 $ 8,355 $ 2,793 103,512 Other operating expenses 31,025 Operating income 72,487 Other expense 26,027 Income before income taxes 46,460 Provision for income taxes 11,994 Net income $ 34,466 * Intersegment revenues of $2.7 million were eliminated from the North American OTC Healthcare segment. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 215,815 $ 20,898 $ 19,860 $ 256,573 Cost of sales 86,501 9,950 16,646 113,097 Gross profit 129,314 10,948 3,214 143,476 Advertising and promotion 32,808 3,690 446 36,944 Contribution margin $ 96,506 $ 7,258 $ 2,768 106,532 Other operating expenses 27,577 Operating income 78,955 Other expense 26,267 Income before income taxes 52,688 Provision for income taxes 18,929 Net income $ 33,759 * Intersegment revenues of $1.4 million were eliminated from the North American OTC Healthcare segment. The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2018 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,258 $ 157 $ — $ 28,415 Cough & Cold 16,214 5,171 — 21,385 Women's Health 63,477 2,257 — 65,734 Gastrointestinal 32,799 5,990 — 38,789 Eye & Ear Care 25,472 2,619 — 28,091 Dermatologicals 25,122 532 — 25,654 Oral Care 22,197 2,667 — 24,864 Other OTC 1,236 1 — 1,237 Household Cleaning — — 19,811 19,811 Total segment revenues $ 214,775 $ 19,394 $ 19,811 $ 253,980 Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 29,290 $ 509 $ — $ 29,799 Cough & Cold 17,410 4,613 — 22,023 Women's Health 63,145 3,594 — 66,739 Gastrointestinal 30,430 5,733 — 36,163 Eye & Ear Care 25,271 3,055 — 28,326 Dermatologicals 24,131 501 — 24,632 Oral Care 24,892 2,892 — 27,784 Other OTC 1,246 1 — 1,247 Household Cleaning — — 19,860 19,860 Total segment revenues $ 215,815 $ 20,898 $ 19,860 $ 256,573 Our total segment revenues by geographic area are as follows: Three Months Ended June 30, 2018 2017 United States $ 223,477 $ 224,994 Rest of world 30,503 31,579 Total $ 253,980 $ 256,573 Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2018 North American OTC International OTC Household Consolidated (In thousands) Goodwill $ 580,934 $ 32,032 $ — $ 612,966 Intangible assets Indefinite-lived 2,375,737 80,915 — 2,456,652 Finite-lived, net 260,114 5,776 — 265,890 Intangible assets, net 2,635,851 86,691 — 2,722,542 Total $ 3,216,785 $ 118,723 $ — $ 3,335,508 (a) As noted in Note 3, goodwill and intangible assets associated with our Household Cleaning segment have been reclassified to Assets held for sale. March 31, 2018 North American OTC International OTC Household Consolidated (In thousands) Goodwill $ 580,934 $ 32,919 $ 6,245 $ 620,098 Intangible assets Indefinite-lived 2,375,736 84,006 30,561 2,490,303 Finite-lived, net 265,356 6,068 19,189 290,613 Intangible assets, net 2,641,092 90,074 49,750 2,780,916 Total $ 3,222,026 $ 122,993 $ 55,995 $ 3,401,014 Our goodwill and intangible assets by geographic area are as follows: June 30, 2018 March 31, 2018 United States $ 3,216,785 $ 3,278,021 Rest of world 118,723 122,993 Total $ 3,335,508 $ 3,401,014

Subsequent Events

Subsequent Events	3 Months Ended
Subsequent Events	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Sale of Household Cleaning Business On July 2, 2018, we entered into an Asset Purchase Agreement with KIK International LLC, pursuant to which we sold certain assets, including certain intellectual property rights, associated with our Household Cleaning product business lines. The assets sold represent our Household Cleaning segment. The purchase price was $69.0 million subject to certain adjustments. As a condition of the agreement, we entered into a Transitional Services Agreement on July 2, 2018, under which we will provide certain services to KIK International LLC related to the transition of the business for a specified period of time. We used the proceeds from this sale to repay $50.0 million of long-term debt in July 2018. Director Equity Grants Pursuant to the Plan, each of the independent members of the Board of Directors received a grant of 3,779 RSUs on July 31, 2018. The RSUs are fully vested upon receipt of the award and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.

Business and Basis of Present25

Business and Basis of Presentation (Policies)	3 Months Ended
Business and Basis of Presentation (Policies)	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., “ 2019 ”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2018 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2019 . These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2018 .
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.
Reclassification	Reclassification In accordance with Accounting Standards Update ("ASU") 2017-07, we have reclassified net periodic benefit costs related to our pension plans from general and administrative expense to other (income) expense. The impact of this reclassification on our financial statements was less than $1.0 million .
Recently Adopted and Issued Accounting Standards	Recently Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , including new FASB Accounting Standards Codification ("ASC") 606, which supersedes the revenue recognition requirements in FASB ASC 605. Along with amendments issued in 2015 and 2016, the new guidance eliminates industry-specific revenue recognition guidance under current GAAP and replaces it with a principle-based approach for determining revenue. The core principle of the new guidance is that an entity should recognize revenue for the transfer of goods and services equal to an amount it expects to be entitled to receive for those goods and services. The new standard also requires additional disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. The new guidance permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively by recognizing the cumulative effect of initially applying the guidance to all contracts existing at the date of initial application (the modified retrospective method). The ASU, as amended, is effective for annual reporting periods beginning after December 15, 2017. We adopted this guidance effective April 1, 2018 using the modified retrospective transition method and applied it to contracts that were not completed at the adoption date. See Note 2 for our revenue recognition policy. The effects of this recently adopted accounting pronouncement to our consolidated balance sheet as of April 1, 2018 are as follows: (In thousands) Balance March 31, 2018 New Revenue Standard Adjustment Balance April 1, 2018 Accounts receivable, net $ 140,881 $ 5,438 $ 146,319 Inventories 118,547 (1,768 ) 116,779 Other accrued liabilities 52,101 1,925 54,026 Deferred income tax liabilities 442,518 401 442,919 Retained earnings 736,277 1,344 737,621 In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which changes the presentation of net periodic benefit cost related to employer sponsored defined benefit plans and other postretirement benefits. Under this ASU, service cost should be included in the same income statement line item as other compensation costs arising from services rendered during the period, while other components of net periodic benefit pension cost should be presented separately outside of operating income. Additionally, only service costs may be capitalized in assets. Entities should apply the guidance on the presentation of the components of net periodic benefit cost in the income statement retrospectively. The guidance limiting the capitalization of net periodic benefit cost in assets to the service cost component should be applied prospectively. The standard is effective for annual reporting periods beginning after December 15, 2017. The adoption of this standard in the first quarter of 2019 required us to reclassify certain pension costs out of operating income and did not have a material impact on our consolidated financial statements. In March 2018, the FASB issued ASU 2018-05, Income Taxes (Topic 740) . The amendments in this update reflect the income tax accounting implications of the Tax Cuts and Jobs Act ("Tax Act"). See Note 14 for a discussion of the Tax Act, which was signed into law on December 22, 2017, and the impact it has had, and may have, on our business and financial results. In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . The amendments in this update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. See Note 14 for a discussion of the Tax Act, which was signed into law on December 22, 2017, and the impact it has had, and may have, on our business and financial results. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We have early adopted ASU 2018-02, and the adoption did not have a material impact on our consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. We adopted this standard effective April 1, 2018 and the adoption did not have a material impact to our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments . The amendments in this update provide clarification and guidance on eight cash flow classification issues. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. We adopted this standard effective April 1, 2018, and the adoption did not have a material impact to our consolidated financial statements. Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) . The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our consolidated financial statements and whether to early adopt this ASU. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB ASC Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are in the process of analyzing our lease portfolio and evaluating the impact of adopting this guidance on our consolidated financial statements.
Revenue Recognition	Revenue Recognition Nature of Goods and Services We recognize revenue from product sales. We primarily ship finished goods to our customers and operate in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The segments are based on differences in the nature of products and geographical area. The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough & Cold, Women's Health, Gastrointestinal, Eye & Ear Care, Dermatologicals, and Oral Care. The Household Cleaning segment focuses on the sale of cleaning products. Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation. We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers and drug, food, dollar, convenience and club stores and e-commerce channels, all of which sell our products to consumers. See Note 18 for disaggregated revenue information. Satisfaction of Performance Obligations Revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to in exchange for that good. This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer’s carrier. This represents a change in the timing of revenue recognition for some sales. Refer to the table above in Note 1 for a disclosure of the adoption date impacts. Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. Variable Consideration Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales. We record an estimate of future product returns concurrent with recording sales, which is made using the most likely amount method which incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. We participate in the promotional programs of our customers to enhance the sale of our products. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place. Estimates of the costs of these promotional programs are derived using the most likely amount method which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. At the completion of the promotional program, the estimated amounts are adjusted to actual results. Practical Expedients Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to remaining performance obligations disclosure. Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time. Accordingly, we have elected the practical expedient available under ASC 606 not to disclose remaining performance obligations for our contracts. The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less. As such, we do not adjust product consideration for the effects of a significant financing component. The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. As such, we expense commission and broker fees as incurred. We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.

Business and Basis of Present26

Business and Basis of Presentation (Tables)	3 Months Ended
Business and Basis of Presentation (Tables)	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Effects of Recently Adopted Accounting Pronouncement	The effects of this recently adopted accounting pronouncement to our consolidated balance sheet as of April 1, 2018 are as follows: (In thousands) Balance March 31, 2018 New Revenue Standard Adjustment Balance April 1, 2018 Accounts receivable, net $ 140,881 $ 5,438 $ 146,319 Inventories 118,547 (1,768 ) 116,779 Other accrued liabilities 52,101 1,925 54,026 Deferred income tax liabilities 442,518 401 442,919 Retained earnings 736,277 1,344 737,621 The impact of adopting ASC 606 on our Condensed Consolidated Statements of Income and Comprehensive Income is as follows: Three Months Ended June 30, 2018 (In thousands) As Reported Impact of Change Without Adoption of ASC 606 Total revenues $ 253,980 $ (5,945 ) $ 248,035 Cost of sales $ 113,357 $ (2,192 ) $ 111,165 Total operating expenses $ 68,136 $ (139 ) $ 67,997 Provision for income taxes $ 11,994 $ (981 ) $ 11,013 Net income $ 34,466 $ (2,633 ) $ 31,833

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
Revenue Recognition (Tables)	Jun. 30, 2018
Revenue from Contract with Customer [Abstract]
Reconciliation of Revenue	The effects of this recently adopted accounting pronouncement to our consolidated balance sheet as of April 1, 2018 are as follows: (In thousands) Balance March 31, 2018 New Revenue Standard Adjustment Balance April 1, 2018 Accounts receivable, net $ 140,881 $ 5,438 $ 146,319 Inventories 118,547 (1,768 ) 116,779 Other accrued liabilities 52,101 1,925 54,026 Deferred income tax liabilities 442,518 401 442,919 Retained earnings 736,277 1,344 737,621 The impact of adopting ASC 606 on our Condensed Consolidated Statements of Income and Comprehensive Income is as follows: Three Months Ended June 30, 2018 (In thousands) As Reported Impact of Change Without Adoption of ASC 606 Total revenues $ 253,980 $ (5,945 ) $ 248,035 Cost of sales $ 113,357 $ (2,192 ) $ 111,165 Total operating expenses $ 68,136 $ (139 ) $ 67,997 Provision for income taxes $ 11,994 $ (981 ) $ 11,013 Net income $ 34,466 $ (2,633 ) $ 31,833

Assets Held for Sale (Tables)

Assets Held for Sale (Tables)	3 Months Ended
Assets Held for Sale (Tables)	Jun. 30, 2018
Discontinued Operations and Disposal Groups [Abstract]
Assets Held for Sale	The total assets held for sale related to this sale were: (In thousands) June 30, 2018 Components of assets held for sale: Inventories $ 6,644 Property, plant and equipment, net 662 Goodwill 6,245 Intangible assets, net 49,315 Assets held for sale $ 62,866

Inventories (Tables)

Inventories (Tables)	3 Months Ended
Inventories (Tables)	Jun. 30, 2018
Inventory Disclosure [Abstract]
Inventories	Inventories consist of the following: (In thousands) June 30, 2018 March 31, 2018 Components of Inventories Packaging and raw materials $ 16,197 $ 13,112 Work in process 223 157 Finished goods 102,537 105,278 Inventories $ 118,957 $ 118,547

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
Goodwill (Tables)	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Goodwill	A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC International OTC Household Consolidated Balance - March 31, 2018 Goodwill $ 711,104 $ 32,919 $ 71,405 $ 815,428 Accumulated impairment loss (130,170 ) — (65,160 ) (195,330 ) Balance - March 31, 2018 580,934 32,919 6,245 620,098 2019 Reclassified to assets held for sale — — (6,245 ) (6,245 ) Effects of foreign currency exchange rates — (887 ) — (887 ) Balance - June 30, 2018 Goodwill 711,104 32,032 65,160 808,296 Accumulated impairment loss (130,170 ) — (65,160 ) (195,330 ) Balance - June 30, 2018 $ 580,934 $ 32,032 $ — $ 612,966

Intangible Assets, net (Tables)

Intangible Assets, net (Tables)	3 Months Ended
Intangible Assets, net (Tables)	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Finite Lived Intangible Assets	A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2018 $ 2,490,303 $ 441,314 $ 2,931,617 Reclassified to assets held for sale (30,562 ) (34,889 ) (65,451 ) Effects of foreign currency exchange rates (3,089 ) (190 ) (3,279 ) Balance — June 30, 2018 2,456,652 406,235 2,862,887 Accumulated Amortization Balance — March 31, 2018 — 150,701 150,701 Additions — 5,812 5,812 Reclassified to assets held for sale — (16,136 ) (16,136 ) Effects of foreign currency exchange rates — (32 ) (32 ) Balance — June 30, 2018 — 140,345 140,345 Intangible assets, net — June 30, 2018 $ 2,456,652 $ 265,890 $ 2,722,542
Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets	A reconciliation of the activity affecting intangible assets, net is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2018 $ 2,490,303 $ 441,314 $ 2,931,617 Reclassified to assets held for sale (30,562 ) (34,889 ) (65,451 ) Effects of foreign currency exchange rates (3,089 ) (190 ) (3,279 ) Balance — June 30, 2018 2,456,652 406,235 2,862,887 Accumulated Amortization Balance — March 31, 2018 — 150,701 150,701 Additions — 5,812 5,812 Reclassified to assets held for sale — (16,136 ) (16,136 ) Effects of foreign currency exchange rates — (32 ) (32 ) Balance — June 30, 2018 — 140,345 140,345 Intangible assets, net — June 30, 2018 $ 2,456,652 $ 265,890 $ 2,722,542

Other Accrued Liabilities (Tabl

Other Accrued Liabilities (Tables)	3 Months Ended
Other Accrued Liabilities (Tables)	Jun. 30, 2018
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other accrued liabilities consist of the following: (In thousands) June 30, 2018 March 31, 2018 Accrued marketing costs $ 26,772 $ 21,473 Accrued compensation costs 4,658 10,591 Accrued broker commissions 1,174 1,487 Income taxes payable 18 1,901 Accrued professional fees 1,997 2,244 Accrued production costs 8,747 7,392 Other accrued liabilities 6,645 7,013 $ 50,011 $ 52,101

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
Long-Term Debt (Tables)	Jun. 30, 2018
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, 2018 March 31, 2018 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 600,000 $ 600,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00% with a floor of 1.00% due on January 26, 2024. 938,000 938,000 2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on January 26, 2022. 75,000 75,000 Long-term debt 2,013,000 2,013,000 Less: unamortized debt costs (19,197 ) (20,048 ) Long-term debt, net $ 1,993,803 $ 1,992,952
Aggregate Future Principal Payments	As of June 30, 2018 , aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the 6.375% senior unsecured notes due 2024 (the "2016 Senior Notes") and the 5.375% senior unsecured notes due 2021 (the "2013 Senior Notes") are as follows: (In thousands) Year Ending March 31, Amount 2019 (remaining nine months ending March 31, 2019) $ — 2020 — 2021 — 2022 475,000 2023 437 Thereafter 1,537,563 $ 2,013,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
Fair Value Measurements (Tables)	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Summary of Carry Amounts and Fair Value Measurements	As such, the 2016 Senior Notes, the 2013 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2018 and March 31, 2018 ). June 30, 2018 March 31, 2018 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 600,000 $ 597,000 $ 600,000 $ 610,500 2013 Senior Notes 400,000 401,000 400,000 402,000 2012 Term B-5 Loans 938,000 934,483 938,000 939,173 2012 ABL Revolver 75,000 75,000 75,000 75,000

Accumulated Other Comprehensi35

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Loss	Accumulated other comprehensive loss consisted of the following at June 30, 2018 and March 31, 2018 : (In thousands) June 30, 2018 March 31, 2018 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (23,372 ) $ (20,398 ) Unrecognized net gain on pension plans 1,083 1,083 Accumulated other comprehensive loss, net of tax $ (22,289 ) $ (19,315 )

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
Earnings Per Share (Tables)	Jun. 30, 2018
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2018 2017 Numerator Net income $ 34,466 $ 33,759 Denominator Denominator for basic earnings per share — weighted average shares outstanding 52,640 53,038 Dilutive effect of nonvested restricted stock units and options issued to employees and directors 302 471 Denominator for diluted earnings per share 52,942 53,509 Earnings per Common Share: Basic earnings per share $ 0.65 $ 0.64 Diluted earnings per share $ 0.65 $ 0.63

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
Share-Based Compensation (Tables)	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Restricted Shares	A summary of the RSUs granted under the Plan is presented below: RSUs Shares (in thousands) Weighted- Average Grant-Date Fair Value Three Months Ended June 30, 2017 Vested and nonvested at March 31, 2017 350.1 $ 39.29 Granted 90.4 56.11 Vested and issued (50.8 ) 34.28 Forfeited (2.3 ) 50.06 Vested and nonvested at June 30, 2017 387.4 43.81 Vested at June 30, 2017 63.7 20.31 Three Months Ended June 30, 2018 Vested and nonvested at March 31, 2018 393.5 $ 44.13 Granted 203.8 29.46 Vested and issued (173.4 ) 43.00 Forfeited (31.1 ) 48.32 Vested and nonvested at June 30, 2018 392.8 36.68 Vested at June 30, 2018 90.5 29.88
Fair Value of Options Granted	The weighted-average grant-date fair values of the options granted during the three months ended June 30, 2018 and 2017 were $10.22 and $21.20 , respectively. Three Months Ended June 30, 2018 2017 Expected volatility 29.6 % 35.2 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 2.9 % 2.2 %
Stock Option Activity	A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three Months Ended June 30, 2017 Outstanding at March 31, 2017 772.3 $ 37.70 Granted 182.8 56.11 Exercised (13.8 ) 31.35 Forfeited or expired (5.8 ) 32.64 Outstanding at June 30, 2017 935.5 41.42 7.7 $ 12,123 Exercisable at June 30, 2017 527.3 31.95 6.5 $ 11,305 Three Months Ended June 30, 2018 Outstanding at March 31, 2018 873.2 $ 41.79 Granted 294.5 29.46 Exercised (32.8 ) 26.81 Forfeited or expired (72.7 ) 45.00 Outstanding at June 30, 2018 1,062.2 38.61 7.6 $ 6,573 Exercisable at June 30, 2018 599.8 37.99 6.2 $ 4,054

Employee Retirement Plans (Tabl

Employee Retirement Plans (Tables)	3 Months Ended
Employee Retirement Plans (Tables)	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Primary Components of Net Periodic Benefits	The primary components of Net Periodic Benefits consist of the following: (In thousands) Three Months Ended June 30, 2018 Three Months Ended June 30, 2017 Interest cost $ 610 629 Expected return on assets (768 ) (726 ) Net periodic benefit income $ (158 ) $ (97 )

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
Business Segments (Tables)	Jun. 30, 2018
Segment Reporting [Abstract]
Information about our Operating and Reportable Segments	The tables below summarize information about our reportable segments Three Months Ended June 30, 2018 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 214,775 $ 19,394 $ 19,811 $ 253,980 Cost of sales 89,153 7,616 16,588 113,357 Gross profit 125,622 11,778 3,223 140,623 Advertising and promotion 33,258 3,423 430 37,111 Contribution margin $ 92,364 $ 8,355 $ 2,793 103,512 Other operating expenses 31,025 Operating income 72,487 Other expense 26,027 Income before income taxes 46,460 Provision for income taxes 11,994 Net income $ 34,466 * Intersegment revenues of $2.7 million were eliminated from the North American OTC Healthcare segment. Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Cleaning Consolidated Total segment revenues* $ 215,815 $ 20,898 $ 19,860 $ 256,573 Cost of sales 86,501 9,950 16,646 113,097 Gross profit 129,314 10,948 3,214 143,476 Advertising and promotion 32,808 3,690 446 36,944 Contribution margin $ 96,506 $ 7,258 $ 2,768 106,532 Other operating expenses 27,577 Operating income 78,955 Other expense 26,267 Income before income taxes 52,688 Provision for income taxes 18,929 Net income $ 33,759 * Intersegment revenues of $1.4 million were eliminated from the North American OTC Healthcare segment.
Information about our Revenues from Similar Product Groups	The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2018 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,258 $ 157 $ — $ 28,415 Cough & Cold 16,214 5,171 — 21,385 Women's Health 63,477 2,257 — 65,734 Gastrointestinal 32,799 5,990 — 38,789 Eye & Ear Care 25,472 2,619 — 28,091 Dermatologicals 25,122 532 — 25,654 Oral Care 22,197 2,667 — 24,864 Other OTC 1,236 1 — 1,237 Household Cleaning — — 19,811 19,811 Total segment revenues $ 214,775 $ 19,394 $ 19,811 $ 253,980 Three Months Ended June 30, 2017 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 29,290 $ 509 $ — $ 29,799 Cough & Cold 17,410 4,613 — 22,023 Women's Health 63,145 3,594 — 66,739 Gastrointestinal 30,430 5,733 — 36,163 Eye & Ear Care 25,271 3,055 — 28,326 Dermatologicals 24,131 501 — 24,632 Oral Care 24,892 2,892 — 27,784 Other OTC 1,246 1 — 1,247 Household Cleaning — — 19,860 19,860 Total segment revenues $ 215,815 $ 20,898 $ 19,860 $ 256,573
Information about our Segment Revenues by Geographic Area	Our total segment revenues by geographic area are as follows: Three Months Ended June 30, 2018 2017 United States $ 223,477 $ 224,994 Rest of world 30,503 31,579 Total $ 253,980 $ 256,573
Information about our Consolidated Goodwil and Intangible Assets Allocated to Reportable Segments	Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2018 North American OTC International OTC Household Consolidated (In thousands) Goodwill $ 580,934 $ 32,032 $ — $ 612,966 Intangible assets Indefinite-lived 2,375,737 80,915 — 2,456,652 Finite-lived, net 260,114 5,776 — 265,890 Intangible assets, net 2,635,851 86,691 — 2,722,542 Total $ 3,216,785 $ 118,723 $ — $ 3,335,508 (a) As noted in Note 3, goodwill and intangible assets associated with our Household Cleaning segment have been reclassified to Assets held for sale. March 31, 2018 North American OTC International OTC Household Consolidated (In thousands) Goodwill $ 580,934 $ 32,919 $ 6,245 $ 620,098 Intangible assets Indefinite-lived 2,375,736 84,006 30,561 2,490,303 Finite-lived, net 265,356 6,068 19,189 290,613 Intangible assets, net 2,641,092 90,074 49,750 2,780,916 Total $ 3,222,026 $ 122,993 $ 55,995 $ 3,401,014
Information about our Goodwill and Intangible Assets by Geographic Area	Our goodwill and intangible assets by geographic area are as follows: June 30, 2018 March 31, 2018 United States $ 3,216,785 $ 3,278,021 Rest of world 118,723 122,993 Total $ 3,335,508 $ 3,401,014

Business and Basis of Present40

Business and Basis of Presentation (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Ownership percentage, subsidiaries	100.00%
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
General and administrative (less than $1.0 million)	$ (23,941)	$ (20,410)
Other expense (income), net	87	$ (74)
Accounting Standards Update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
General and administrative (less than $1.0 million)	1,000
Other expense (income), net	$ 1,000

Business and Basis of Present41

Business and Basis of Presentation (Effects of Recently Adopted Accounting Pronouncement) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Apr. 01, 2018	Mar. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accounts receivable, net	$ 150,390	$ 146,319	$ 140,881
Inventories	118,957	116,779	118,547
Other accrued liabilities	50,011	54,026	52,101
Deferred income tax liabilities	447,855	442,919	442,518
Retained earnings	$ 772,086	737,621	736,277
Calculated under Revenue Guidance in Effect before Topic 606
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accounts receivable, net			140,881
Inventories			118,547
Other accrued liabilities			52,101
Deferred income tax liabilities			442,518
Retained earnings			$ 736,277
Difference between Revenue Guidance in Effect before and after Topic 606 \| New Revenue Standard Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accounts receivable, net		5,438
Inventories		(1,768)
Other accrued liabilities		1,925
Deferred income tax liabilities		401
Retained earnings		$ 1,344

Revenue Recognition (Narrative)

Revenue Recognition (Narrative) (Details)	3 Months Ended
Revenue Recognition (Narrative) (Details)	Jun. 30, 2018segment
Revenue from Contract with Customer [Abstract]
Number of operating segments	3
Expected timing of remaining performance obligation, maximum	1 year
Amortization period	1 year

Revenue Recognition (Revenue Re

Revenue Recognition (Revenue Reconciliation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total revenues	$ 253,980	$ 256,573
Cost of sales	113,357	113,097
Total operating expenses	68,136	64,521
Provision for income taxes	11,994	18,929
Net income	34,466	$ 33,759
Impact of Change \| New Revenue Standard Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total revenues	(5,945)
Cost of sales	(2,192)
Total operating expenses	(139)
Provision for income taxes	(981)
Net income	(2,633)
Without Adoption of ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total revenues	248,035
Cost of sales	111,165
Total operating expenses	67,997
Provision for income taxes	11,013
Net income	$ 31,833

Assets Held for Sale (Details)

Assets Held for Sale (Details) - USD ($) $ in Thousands	Jul. 02, 2018	Jun. 30, 2018	Mar. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale		$ 62,866	$ 0
Disposal group, held-for-sale, not discontinued operations \| Household Cleaning
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Inventories		6,644
Property, plant and equipment, net		662
Goodwill		6,245
Assets held for sale		49,315
Assets held for sale		$ 62,866
Household Cleaning \| Subsequent Event \| Disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Divestiture of Businesses	$ 0

Inventories (Components of Inv

Inventories (Components of Inventories) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Apr. 01, 2018	Mar. 31, 2018
Inventory Disclosure [Abstract]
Packaging and raw materials	$ 16,197		$ 13,112
Work in process	223		157
Finished goods	102,537		105,278
Inventories	118,957	$ 116,779	118,547
Inventory valuation reserves related to obsolete and slow-moving inventory	$ 2,800		$ 4,200

Goodwill (Schedule of Segment G

Goodwill (Schedule of Segment Goodwill) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Mar. 31, 2018
Goodwill [Line Items]
Goodwill	$ 808,296	$ 815,428
Accumulated impairment loss	(195,330)	(195,330)
Goodwill [Roll Forward]
Balance — March 31, 2018	620,098
Reclassified to assets held for sale	(6,245)
Effects of foreign currency exchange rates	(887)
Balance — June 30, 2018	612,966
North American OTC Healthcare
Goodwill [Line Items]
Goodwill	711,104	711,104
Accumulated impairment loss	(130,170)	(130,170)
Goodwill [Roll Forward]
Balance — March 31, 2018	580,934
Reclassified to assets held for sale	0
Effects of foreign currency exchange rates	0
Balance — June 30, 2018	580,934
International OTC Healthcare
Goodwill [Line Items]
Goodwill	32,032	32,919
Accumulated impairment loss	0	0
Goodwill [Roll Forward]
Balance — March 31, 2018	32,919
Reclassified to assets held for sale	0
Effects of foreign currency exchange rates	(887)
Balance — June 30, 2018	32,032
Household Cleaning
Goodwill [Roll Forward]
Reclassified to assets held for sale	(6,245)
Household Cleaning
Goodwill [Line Items]
Goodwill	65,160	71,405
Accumulated impairment loss	(65,160)	$ (65,160)
Goodwill [Roll Forward]
Balance — March 31, 2018	6,245
Effects of foreign currency exchange rates	0
Balance — June 30, 2018	$ 0

Goodwill (Narrative) (Details)

Goodwill (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
Goodwill (Narrative) (Details) - USD ($)	Jun. 30, 2018	Mar. 31, 2018
Goodwill [Line Items]
Decrease in goodwill related to sell of segment	$ 6,245,000
Goodwill impairment		$ 0
Household Cleaning
Goodwill [Line Items]
Decrease in goodwill related to sell of segment	$ 6,245,000

Intangible Assets, net (Schedul

Intangible Assets, net (Schedule of Reconciliation of Activity Affecting Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Mar. 31, 2018
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	$ 2,490,303
Indefinite Lived Trademarks, ending balance	2,456,652
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks and Customer Relationships, accumulated amortization, beginning balance	150,701
Accumulated amortization, additions	5,812	$ 5,900
Reclassified to assets held for sale	(16,136)
Accumulated amortization, effects of foreign exchange rates	(32)
Finite Lived Trademarks and Customer Relationships, accumulated amortization, ending balance	140,345
Intangible Assets, Gross [Abstract]
Totals, gross, beginning balance	2,931,617
Total, gross, reclassified to assets held for sale	(65,451)
Totals, effects of foreign currency exchange rate	(3,279)
Totals, gross, ending balance	2,862,887
Finite-Lived Intangible Assets, Net [Abstract]
Finite-lived, net	265,890		$ 290,613
Intangible Assets, Net [Abstract]
Intangible assets, net	2,722,542		$ 2,780,916
Finite Lived Trademarks and Customer Relationships
Finite-Lived Intangible Assets, Gross [Abstract]
Finite Lived Trademarks and Customer Relationships, beginning balance	441,314
Finite-lived Trademarks and Customer Relationships, reclassified to assets held for sale	(34,889)
Finite Lived Trademarks and Customer Relationships, effects of foreign currency exchange rate	(190)
Finite Lived Trademarks and Customer Relationships, ending balance	406,235
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks and Customer Relationships, accumulated amortization, beginning balance	150,701
Accumulated amortization, additions	5,812
Reclassified to assets held for sale	(16,136)
Accumulated amortization, effects of foreign exchange rates	(32)
Finite Lived Trademarks and Customer Relationships, accumulated amortization, ending balance	140,345
Finite-Lived Intangible Assets, Net [Abstract]
Finite-lived, net	265,890
Indefinite Lived Trademarks
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	2,490,303
Indefinite-Lived Trademarks, reclassified to assets held for sale	(30,562)
Indefinite Lived Trademarks, effects of foreign currency exchange rate	(3,089)
Indefinite Lived Trademarks, ending balance	$ 2,456,652

Intangible Assets, net (Narrati

Intangible Assets, net (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 5,812	$ 5,900
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of the year	16,100
2,019	21,500
2,020	21,100
2,021	20,600
2,022	20,600
2,023	20,600
Trademarks \| Household Cleaning
Finite-Lived Intangible Assets [Line Items]
Finite lived intangibles, reclassified to assets held for sale	18,800
Indefinite Lived Trademarks
Finite-Lived Intangible Assets [Line Items]
Indefinite lived intangibles, reclassified to assets held for sale	30,562
Indefinite Lived Trademarks \| Household Cleaning
Finite-Lived Intangible Assets [Line Items]
Indefinite lived intangibles, reclassified to assets held for sale	$ 30,500

Other Accrued Liabilities (Summ

Other Accrued Liabilities (Summary of Accrued Liabilities and Accounts Payable) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Apr. 01, 2018	Mar. 31, 2018
Payables and Accruals [Abstract]
Accrued marketing costs	$ 26,772		$ 21,473
Accrued compensation costs	4,658		10,591
Accrued broker commissions	1,174		1,487
Income taxes payable	18		1,901
Accrued professional fees	1,997		2,244
Accrued production costs	8,747		7,392
Other accrued liabilities	6,645		7,013
Total other accrued liabilities	$ 50,011	$ 54,026	$ 52,101

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($)	Jun. 30, 2018	Mar. 31, 2018
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	$ 1,993,803,000	$ 1,992,952,000
2012 ABL Revolver \| Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	75,000,000
Line of credit facility, additional borrowing capacity	$ 98,900,000
Senior Notes \| 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	6.375%
Senior Notes \| 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	5.375%

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Mar. 31, 2018
Debt Instrument [Line Items]
Total long-term debt (including current portion)	$ 2,013,000	$ 2,013,000
Less: unamortized debt costs	(19,197)	(20,048)
Long-term debt, net	1,993,803	1,992,952
2012 ABL Revolver \| Revolving Credit Facility
Debt Instrument [Line Items]
Total long-term debt (including current portion)	75,000	75,000
Long-term debt, net	$ 75,000
Senior Notes \| 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	6.375%
Total long-term debt (including current portion)	$ 600,000	600,000
Senior Notes \| 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	5.375%
Total long-term debt (including current portion)	$ 400,000	400,000
Term B-5 Loans \| 2012 Senior Notes
Debt Instrument [Line Items]
Total long-term debt (including current portion)	$ 938,000	$ 938,000
Term B-5 Loans \| 2012 Senior Notes \| LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)	2.00%
Debt instrument, variable rate, minimum (as percent)	0.00%
Term B-5 Loans \| 2012 Senior Notes \| Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)	1.00%
Debt instrument, variable rate, minimum (as percent)	1.00%

Long-Term Debt (Maturities of L

Long-Term Debt (Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Aggregate Future Principal Payments
2019 (remaining nine months ending March 31, 2019)	$ 0
2,020	0
2,021	0
2,022	475,000
2,023	437
Thereafter	1,537,563
Total long-term debt (including current portion)	$ 2,013,000	$ 2,013,000

Fair Value Measurements (Summar

Fair Value Measurements (Summary of Carrying Amounts and Estimated Fair Values) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Senior Notes \| 2016 Senior Notes \| Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	$ 600,000	$ 600,000
Senior Notes \| 2013 Senior Notes \| Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	400,000	400,000
Term Loans \| Term B-4 Loans \| Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	938,000	938,000
Revolving Credit Facility \| 2012 ABL Revolver \| Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	75,000	75,000
Fair Value, Measurements, Recurring \| Senior Notes \| 2016 Senior Notes \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	597,000	610,500
Fair Value, Measurements, Recurring \| Senior Notes \| 2013 Senior Notes \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	401,000	402,000
Fair Value, Measurements, Recurring \| Term Loans \| Term B-4 Loans \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	934,483	939,173
Fair Value, Measurements, Recurring \| Revolving Credit Facility \| 2012 ABL Revolver \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	$ 75,000	$ 75,000

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details)	3 Months Ended
Stockholders' Equity (Narrative) (Details)	Jun. 30, 2018USD ($)vote$ / sharesshares	Jun. 30, 2017$ / sharesshares	Mar. 31, 2018$ / sharesshares
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares	250,000,000		250,000,000
Common stock, par value (in USD per share) \| $ / shares	$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares) \| shares	5,000,000		5,000,000
Preferred stock, par value (in USD per share) \| $ / shares	$ 0.01		$ 0.01
Voting rights, number of votes per common share owned \| vote	1
Dividends declared on common stock \| $	$ 0
Stock repurchased during period (in shares) \| shares	1,449,750
Stock acquired, average cost per share (in USD per share) \| $ / shares	$ 34.47
Treasury stock acquired \| $	$ 50,000,000
Restricted Shares
Class of Stock [Line Items]
Stock repurchased during period (in shares) \| shares	68,939	19,616
Stock acquired, average cost per share (in USD per share) \| $ / shares	$ 33.09	$ 52.36

Accumulated Other Comprehensi56

Accumulated Other Comprehensive Loss (Components of AOCI) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of accumulated other comprehensive loss	$ 1,161,723,000	$ 1,178,610,000
Reclassification from accumulated other comprehensive loss into earnings	0	0
Cumulative translation adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of accumulated other comprehensive loss	(23,372,000)	(20,398,000)
Unrecognized net gain on pension plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of accumulated other comprehensive loss	1,083,000	1,083,000
Accumulated other comprehensive loss, net of tax
Accumulated Other Comprehensive Income (Loss) [Line Items]
Components of accumulated other comprehensive loss	$ (22,289,000)	$ (19,315,000)

Earnings Per Share (Computation

Earnings Per Share (Computation of Basis and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Numerator
Net income	$ 34,466	$ 33,759
Denominator
Denominator for basic earnings per share — weighted average shares outstanding (in shares)	52,640	53,038
Dilutive effect of nonvested restricted stock units and options issued to employees and directors (in shares)	302	471
Denominator for diluted earnings per share (in shares)	52,942	53,509
Earnings per Common Share:
Basic earnings per share (in USD per share)	$ 0.65	$ 0.64
Diluted earnings per share (in USD per share)	$ 0.65	$ 0.63

Earnings Per Share (Antidilutiv

Earnings Per Share (Antidilutive Securities) (Details) - shares shares in Millions	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Outstanding Stock Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0.8	0.4

Share-Based Compensation (Narra

Share-Based Compensation (Narrative) (Details) $ / shares in Units, $ in Thousands	May 07, 2018$ / sharesshares	May 31, 2014shares	Jun. 30, 2014shares	Jun. 30, 2018USD ($)shares$ / shares	Jun. 30, 2017USD ($)$ / sharesshares
Share-based Compensation, Aggregate Disclosures:
Maximum number of shares per participant, 12 month period (in shares)		1,000,000	2,500,000
Extension of plan term			10 years
Share-based compensation costs charged against income \| $				$ 1,700	$ 1,700
Tax benefit recognized from share-based compensation expense \| $				200	500
Unrecognized compensation costs related to nonvested awards \| $				$ 11,300
Unrecognized compensation costs related to nonvested awards, weighted average period for recognition				1 year 1 month 6 days
Total fair value of vested shares \| $				$ 10,700	4,900
Proceeds from exercise of stock options \| $				880	433
Tax benefit realized from exercise of stock options \| $				$ 1,200	$ 900
Shares available for issuance under the Plan (in shares)				1,800,000
Stock options granted (in shares)				294,500	182,800
Options, Additional Disclosures:
Options granted, weighted-average grant-date fair value (in USD per share) \| $ / shares				$ 10.22	$ 21.20
Options exercised, aggregate intrinsic value \| $				$ 300
Performance Shares
Share-based Compensation, Aggregate Disclosures:
Share grants in period (in shares)	103,406
Restricted Stock Units (RSUs)
Share-based Compensation, Aggregate Disclosures:
Share grants in period (in shares)	100,399			203,800	90,400
Stock Options
Share-based Compensation, Aggregate Disclosures:
Stock options granted (in shares)	294,484
Stock options granted, exercise price (in USD per share) \| $ / shares	$ 29.46
Stock Options \| Minimum
Restricted Shares
Award vesting period				3 years
Stock Options \| Maximum
Restricted Shares
Award vesting period				5 years
Options, Additional Disclosures:
Award exercisability period, from date of grant				10 years
Employee \| Restricted Stock Units (RSUs)
Restricted Shares
Award vesting period				3 years
Employee \| Restricted Stock Units (RSUs) \| Maximum
Restricted Shares
Award vesting period				3 years
Director \| Restricted Stock Units (RSUs)
Restricted Shares
Number of common shares into which each RSU may be converted (in shares)				1
Period following director's term in which RSUs may be settled				6 months
Long-term Equity Incentive Plan, 2005
Share-based Compensation, Aggregate Disclosures:
Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plan (in shares)		5,000,000
Number of additional shares authorized (in shares)			1,800,000

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares	May 07, 2018	Jun. 30, 2018	Jun. 30, 2017
Shares
Outstanding, beginning of period (in shares)		393,500	350,100
Granted (in shares)	100,399	203,800	90,400
Vested and issued (in shares)		(173,400)	(50,800)
Forfeited (in shares)		(31,100)	(2,300)
Outstanding, end of period (in shares)		392,800	387,400
Vested, end of period (in shares)		90,500	63,700
Weighted- Average Grant-Date Fair Value
Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)		$ 44.13	$ 39.29
Granted, weighted-average grant-date fair value (in USD per share)		29.46	56.11
Vested and issued, weighted-average grant-date fair value (in USD per share)		43	34.28
Forfeited, weighted-average grant-date fair value (in USD per share)		48.32	50.06
Outstanding, end of period, weighted-average grant-date fair value (in USD per share)		36.68	43.81
Vested, end of period, weighted-average grant-date fair value (in USD per share)		$ 29.88	$ 20.31

Share-Based Compensation (Stock

Share-Based Compensation (Stock Option Valuation Assumptions) (Details) - Stock Options - USD ($)	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	29.60%	35.20%
Expected dividends	$ 0	$ 0
Expected term in years	6 years	6 years
Risk-free rate	2.90%	2.20%

Share-Based Compensation (Sto62

Share-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Shares
Outstanding, beginning of period (in shares)	873,200	772,300
Granted (in shares)	294,500	182,800
Exercised (in shares)	(32,800)	(13,800)
Forfeited or expired (in shares)	(72,700)	(5,800)
Outstanding, end of period (in shares)	1,062,200	935,500
Exercisable, end of period (in shares)	599,800	527,300
Weighted- Average Exercise Price
Outstanding, beginning of period, weighted-average exercise price (in USD per share)	$ 41.79	$ 37.70
Granted, weighted-average exercise price (in USD per share)	29.46	56.11
Exercised, weighted-average exercise price (in USD per share)	26.81	31.35
Forfeited or expired, weighted-average exercise price (in USD per share)	45	32.64
Outstanding, end of period, weighted-average exercise price (in USD per share)	38.61	41.42
Exercisable, end of period, weighted-average exercise price (in USD per share)	$ 37.99	$ 31.95
Options, Additional Disclosures:
Outstanding, end of period, weighted-average remaining contractual term	7 years 7 months 6 days	7 years 8 months 12 days
Exercisable, end of period, weighted-average remaining contractual term	6 years 2 months 12 days	6 years 6 months
Outstanding, end of period, aggregate intrinsic value	$ 6,573	$ 12,123
Exercisable, end of period, aggregate intrinsic value	$ 4,054	$ 11,305

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Jun. 30, 2018	Jun. 30, 2017	Mar. 31, 2018
Income Tax Disclosure [Abstract]
Net gain related to value of deferred tax liabilities			$ 267
Net gain related to lower blended rate			3.2
Net gain			270.2
Tax cuts and jobs act of 2017, incomplete accounting, transition tax for foreign earnings, provisional income tax expense			1.9
Effective income tax rate (percent)	25.80%	35.90%
Uncertain tax liability	$ 10.8		$ 10.8

Employee Retirement Plans (Expe

Employee Retirement Plans (Expected Return on Plan Assets) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Interest cost	$ 610	$ 629
Expected return on assets	(768)	(726)
Net periodic benefit income	$ (158)	$ (97)

Employee Retirement Plans (Narr

Employee Retirement Plans (Narrative) (Details)	3 Months Ended
Employee Retirement Plans (Narrative) (Details)	Jun. 30, 2018USD ($)
Non-qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions	$ 100,000
Qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions	0
Expected employer contributions, 2019 fiscal year	$ 1,000,000

Concentrations of Risk (Narrati

Concentrations of Risk (Narrative) (Details) - manufacturer	3 Months Ended
Concentrations of Risk (Narrative) (Details) - manufacturer	Jun. 30, 2018	Jun. 30, 2017
Concentration Risk [Line Items]
Number of third-party manufacturers	116	116
Sales \| Customer Concentration Risk \| Walmart
Concentration Risk [Line Items]
Concentration risk, percentage (percent)	24.60%	25.50%
Sales \| Supplier Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (percent)	61.90%	77.20%
Number of third-party manufacturers with long-term contracts	38	48
Accounts Receivable \| Customer Concentration Risk \| Walmart
Concentration Risk [Line Items]
Concentration risk, percentage (percent)	25.20%
Top 5 brands \| Sales \| Product Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage (percent)	42.60%	43.20%

Business Segments (Information

Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting Information, Profit (Loss):
Total revenues	$ 253,980	$ 256,573
Cost of sales	113,357	113,097
Gross profit	140,623	143,476
Advertising and promotion	37,111	36,944
Contribution margin	103,512	106,532
Other operating expenses	31,025	27,577
Operating income	72,487	78,955
Other expense	26,027	26,267
Income before income taxes	46,460	52,688
Provision for income taxes	11,994	18,929
Net income	34,466	33,759
North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	214,775	215,815
Cost of sales		86,501
Gross profit		129,314
Advertising and promotion		32,808
Contribution margin		96,506
International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	19,394	20,898
Cost of sales		9,950
Gross profit		10,948
Advertising and promotion		3,690
Contribution margin		7,258
Household Cleaning
Segment Reporting Information, Profit (Loss):
Total revenues	19,811	19,860
Cost of sales		16,646
Gross profit		3,214
Advertising and promotion		446
Contribution margin		2,768
Operating Segments \| North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	214,775
Cost of sales	89,153
Gross profit	125,622
Advertising and promotion	33,258
Contribution margin	92,364
Operating Segments \| International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	19,394
Cost of sales	7,616
Gross profit	11,778
Advertising and promotion	3,423
Contribution margin	8,355
Operating Segments \| Household Cleaning
Segment Reporting Information, Profit (Loss):
Total revenues	19,811
Cost of sales	16,588
Gross profit	3,223
Advertising and promotion	430
Contribution margin	2,793
Intersegment Eliminations \| North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Total revenues	$ (2,700)	$ (1,400)

Business Segments (Revenue) (De

Business Segments (Revenue) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	$ 253,980	$ 256,573
Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	28,415	29,799
Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	21,385	22,023
Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	65,734	66,739
Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	38,789	36,163
Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	28,091	28,326
Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	25,654	24,632
Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	24,864	27,784
Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	1,237	1,247
Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	19,811	19,860
North American OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	214,775	215,815
North American OTC Healthcare \| Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	28,258	29,290
North American OTC Healthcare \| Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	16,214	17,410
North American OTC Healthcare \| Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	63,477	63,145
North American OTC Healthcare \| Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	32,799	30,430
North American OTC Healthcare \| Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	25,472	25,271
North American OTC Healthcare \| Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	25,122	24,131
North American OTC Healthcare \| Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	22,197	24,892
North American OTC Healthcare \| Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	1,236	1,246
International OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	19,394	20,898
International OTC Healthcare \| Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	157	509
International OTC Healthcare \| Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	5,171	4,613
International OTC Healthcare \| Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	2,257	3,594
International OTC Healthcare \| Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	5,990	5,733
International OTC Healthcare \| Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	2,619	3,055
International OTC Healthcare \| Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	532	501
International OTC Healthcare \| Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	2,667	2,892
International OTC Healthcare \| Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	1	1
Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	19,811	19,860
Household Cleaning \| Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	0	0
Household Cleaning \| Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total revenues	$ 19,811	$ 19,860

Business Segments (Revenue, Goo

Business Segments (Revenue, Goodwill and Intangible Assets by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Mar. 31, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 253,980	$ 256,573
Goodwill and intangible assets, total	3,335,508		$ 3,401,014
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	223,477	224,994
Goodwill and intangible assets, total	3,216,785		3,278,021
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	30,503	$ 31,579
Goodwill and intangible assets, total	$ 118,723		$ 122,993

Business Segments (Goodwill and

Business Segments (Goodwill and Intangible Assets) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	$ 612,966	$ 620,098
Intangible assets
Indefinite-lived	2,456,652	2,490,303
Finite-lived, net	265,890	290,613
Intangible assets, net	2,722,542	2,780,916
Total	3,335,508	3,401,014
North American OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	580,934	580,934
Intangible assets
Indefinite-lived	2,375,737	2,375,736
Finite-lived, net	260,114	265,356
Intangible assets, net	2,635,851	2,641,092
Total	3,216,785	3,222,026
International OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	32,032	32,919
Intangible assets
Indefinite-lived	80,915	84,006
Finite-lived, net	5,776	6,068
Intangible assets, net	86,691	90,074
Total	118,723	122,993
Household Cleaning
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	0	6,245
Intangible assets
Indefinite-lived	0	30,561
Finite-lived, net	0	19,189
Intangible assets, net	0	49,750
Total	$ 0	$ 55,995

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Jul. 31, 2018shares	Jul. 12, 2018USD ($)	Jun. 30, 2018shares	Jul. 02, 2018USD ($)
Restricted Stock Units (RSUs) \| Independent members of Board of Directors
Subsequent Event [Line Items]
Number of common shares into which each RSU may be converted (in shares) \| shares			1
Period following director's term in which RSUs may be settled			6 months
Subsequent Event
Subsequent Event [Line Items]
Repayments of long-term debt \| $		$ 50
Subsequent Event \| Restricted Stock Units (RSUs) \| Independent members of Board of Directors
Subsequent Event [Line Items]
Share grants in period (in shares) \| shares	3,779
Disposed of by sale \| Household Cleaning \| Subsequent Event
Subsequent Event [Line Items]
Consideration for disposal \| $				$ 69